{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:40:07Z","timestamp":1792471207779,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejso.2026.112307","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:47:05Z","timestamp":1792230425000},"page":"112307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world survival scenarios for patients with colorectal cancer and synchronous peritoneal metastases"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0780-3423","authenticated-orcid":false,"given":"Teun ME.","family":"Kerkhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1703-0121","authenticated-orcid":false,"given":"Patricia AH.","family":"Hamers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels FM.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery EPP.","family":"Lemmens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace HJT.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-1429","authenticated-orcid":false,"given":"Felice N.","family":"van Erning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejso.2026.112307_bib1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ejso.2020.11.135","article-title":"Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study","volume":"47","author":"Lurvink","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2026.112307_bib2","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1245\/s10434-021-10190-z","article-title":"Treatment strategies and prognosis of patients with synchronous or metachronous colorectal peritoneal metastases: a population-based study","volume":"28","author":"Bakkers","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112307_bib3","first-page":"369","article-title":"Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience","volume":"21","author":"Kiely","year":"2012","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2026.112307_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ijc.33200","article-title":"Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real\u2010life data","volume":"148","author":"Hamers","year":"2020","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2026.112307_bib5","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/0284186X.2013.777158","article-title":"Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in the Netherlands","volume":"52","author":"Mol","year":"2013","journal-title":"Acta Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.112307_bib6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.112307_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"Von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejso.2026.112307_bib8","series-title":"International classification of diseases for oncology (A. Fritz, C. Percy, A. Jack, K. Shanmugaratnam, L. Sobin, D. M. Parkin, & S. Whelan, Reds.; third)","year":"2013"},{"issue":"2","key":"10.1016\/j.ejso.2026.112307_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.112307_bib10","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1245\/s10434-013-3049-8","article-title":"Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (functional assessment of cancer therapy) and patient-rated performance status","volume":"20","author":"Ihemelandu","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112307_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SLA.0b013e31825704e3","article-title":"Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"256","author":"Baratti","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2026.112307_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2016.10.007","article-title":"The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials","volume":"70","author":"Holch","year":"2016","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2026.112307_bib13","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","article-title":"Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group","volume":"27","author":"Modest","year":"2016","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2026.112307_bib15","first-page":"5689","article-title":"Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: preliminary analysis of a multicentre study","volume":"34","author":"Macr\u00ec","year":"2014","journal-title":"PubMed"},{"issue":"11","key":"10.1016\/j.ejso.2026.112307_bib16","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1245\/s10434-013-3053-z","article-title":"Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality","volume":"20","author":"Votanopoulos","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112307_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jso.24813","article-title":"Clinical studies in CRS and HIPEC: trials, tribulations, and future directions\u2014A systematic review","volume":"117","author":"Morano","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112307_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/CMAR.S119569","article-title":"Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer","volume":"9","author":"Simkens","year":"2017","journal-title":"Cancer Manag Res"},{"issue":"3","key":"10.1016\/j.ejso.2026.112307_bib19","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1245\/s10434-021-10925-y","article-title":"Outcomes of combined peritoneal and local treatment for patients with peritoneal and limited liver metastases of colorectal origin: a systematic review and meta-analysis","volume":"29","author":"Polderdijk","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.112307_bib20","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s11605-022-05390-1","article-title":"Outcomes of stable lung colorectal metastases on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"26","author":"Pantelis","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejso.2026.112307_bib21","author":"Tanis"},{"issue":"9","key":"10.1016\/j.ejso.2026.112307_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.annonc.2024.06.001","article-title":"Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group","volume":"35","author":"Van Der Kruijssen","year":"2024","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112307_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ijc.35356","article-title":"Influence of a nationwide colorectal cancer screening program on the incidence of synchronous colorectal peritoneal metastases","volume":"157","author":"Galanos","year":"2025","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2026.112307_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4613-1247-5_3","article-title":"Pharmacokinetics of the peritoneal-plasma barrier after systemic mitomycin C administration","volume":"82","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"7","key":"10.1016\/j.ejso.2026.112307_bib25","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.112307_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-077667","article-title":"Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial","volume":"14","author":"Van De Vlasakker","year":"2024","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ejso.2026.112307_bib27","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1245\/s10434-020-09558-4","article-title":"Pressurized intraperitoneal aerosol chemotherapy (Oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, Single-Arm, phase II trial (CRC-PIPAC)","volume":"28","author":"Rovers","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.112307_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-044811","volume":"11","author":"Lurvink","year":"2021","journal-title":"BMJ Open"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326009261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326009261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:19:45Z","timestamp":1792469985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326009261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0748798326009261"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112307","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world survival scenarios for patients with colorectal cancer and synchronous peritoneal metastases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112307"}}